Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Bristol-Myers Squibb resubmits UFT NDA to FDA

April 26, 2000

Proapoptotic and antiproliferative chroman-based compounds designed by RDF

April 26, 2000

SafeScience's phase II trial of GBC-590 expanded

April 25, 2000

Lipophilic platinum complex superior to cisplatin in rat hepatic tumor model

April 25, 2000

FDA approves Camptosar as first-line treatment of metastatic colorectal cancer

April 25, 2000

Progen's angiogenesis inhibitor slows tumor growth in rats

April 25, 2000

Biovector Therapeutics initiates phase II trial of melanoma vaccine

April 24, 2000

Apoptosis-initiating gene acquired by Idun

April 24, 2000

Idec enters two agreements for prostate cancer immunotherapy

April 24, 2000

BioInvent to produce therapeutic antibody for Wilex

April 20, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 15, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
GABA signaling linked to immune resistance in some tumors
BioWorld
Certain cancers that contain organized clusters of immune cells known as tertiary lymphoid structures (TLS) do not respond to treatment as well as expected. Even...